Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

A new study in Scientific Reports reveals that skin shame is a key psychological burden for people with atopic dermatitis and ...